- Home
- TC vs EYEN Comparison
TC vs EYEN Comparison
Compare TC & EYEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TC
- EYEN
- Stock Information
- Founded
- TC 2010
- EYEN 2014
- Country
- TC China
- EYEN United States
- Employees
- TC N/A
- EYEN N/A
- Industry
- TC Business Services
- EYEN Biotechnology: Pharmaceutical Preparations
- Sector
- TC Consumer Discretionary
- EYEN Health Care
- Exchange
- TC Nasdaq
- EYEN Nasdaq
- Market Cap
- TC 2.5M
- EYEN 2.9M
- IPO Year
- TC 2018
- EYEN 2018
- Fundamental
- Price
- TC $0.80
- EYEN $10.56
- Analyst Decision
- TC
- EYEN Hold
- Analyst Count
- TC 0
- EYEN 4
- Target Price
- TC N/A
- EYEN $2.00
- AVG Volume (30 Days)
- TC 223.1K
- EYEN 10.0M
- Earning Date
- TC 07-07-2025
- EYEN 08-11-2025
- Dividend Yield
- TC N/A
- EYEN N/A
- EPS Growth
- TC N/A
- EYEN N/A
- EPS
- TC N/A
- EYEN N/A
- Revenue
- TC $6,737,269.00
- EYEN $67,063.00
- Revenue This Year
- TC N/A
- EYEN $7,680.45
- Revenue Next Year
- TC N/A
- EYEN $315.38
- P/E Ratio
- TC N/A
- EYEN N/A
- Revenue Growth
- TC N/A
- EYEN 663.82
- 52 Week Low
- TC $0.46
- EYEN $0.85
- 52 Week High
- TC $4.30
- EYEN $124.80
- Technical
- Relative Strength Index (RSI)
- TC 47.92
- EYEN 68.92
- Support Level
- TC $0.75
- EYEN $7.50
- Resistance Level
- TC $0.81
- EYEN $14.33
- Average True Range (ATR)
- TC 0.07
- EYEN 2.52
- MACD
- TC -0.01
- EYEN 0.60
- Stochastic Oscillator
- TC 16.26
- EYEN 69.15
About TC TuanChe Limited
Token Cat Ltd is an omnichannel automotive marketplace in China. The company operates in one segment, providing auto shows, special promotion event services, virtual dealerships, online marketing services, and more. It organizes auto shows to facilitate transactions between consumers and auto dealers, which include auto dealers, automakers, and automotive service providers. It offers services through its online platform and offline events.
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.